Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Mar;47(3):387–392. doi: 10.1038/bjc.1983.58

Radioprotection by WR-2721 in vitro at low oxygen tensions: implications for its mechanisms of action.

R E Durand
PMCID: PMC2011303  PMID: 6299319

Abstract

Radioprotection of spheroids of Chinese hamster V79 cells by WR-2721 was found to be a function of spheroid size, with the greatest dose-modifying effect by the protector observed for spheroids almost large enough to contain radioresistant "anoxic" cells. The nature of the response suggested that most of the protective effect was due to the presence of an increased hypoxic fraction in the drug-treated spheroids. Similarly, when single-cell suspensions were irradiated at various oxygen tensions, one component of radioprotection by WR-2721 was found to be highly dependent upon the available oxygen. Two mechanisms of radioprotection of V79 cells by WR-2721 were thus demonstrated: a modest, oxygen-independent effect, presumably due to hydrogen donation, and an oxygen-depleting effect, which is of maximal significance for cells or tissues which would otherwise be partially sensitized by low levels of oxygen.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bump E. A., Yu N. Y., Brown J. M. Radiosensitization of hypoxic tumor cells by depletion of intracellular glutathione. Science. 1982 Aug 6;217(4559):544–545. doi: 10.1126/science.7089580. [DOI] [PubMed] [Google Scholar]
  2. Cullen B. M., Michalowski A., Walker H. C., Révész L. Correlation between the radiobiological oxygen constant, K, and the non-protein sulphydryl content of mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1980 Nov;38(5):525–535. doi: 10.1080/09553008014551341. [DOI] [PubMed] [Google Scholar]
  3. Denekamp J., Michael B. D., Rojas A., Stewart F. A. Thiol radioprotection in vivo: the critical role of tissue oxygen concentration. Br J Radiol. 1981 Dec;54(648):1112–1114. doi: 10.1259/0007-1285-54-648-1112-c. [DOI] [PubMed] [Google Scholar]
  4. Durand R. E. Variable radiobiological responses of spheroids. Radiat Res. 1980 Jan;81(1):85–99. [PubMed] [Google Scholar]
  5. Harris J. W. Mammalian cell studies with diamide. Pharmacol Ther. 1979;7(2):375–391. doi: 10.1016/0163-7258(79)90037-8. [DOI] [PubMed] [Google Scholar]
  6. Harris J. W., Phillips T. L. Radiobiolgoical and biochemical studies of thiophosphate radioprotective compounds related to cysteamine. Radiat Res. 1971 May;46(2):362–379. [PubMed] [Google Scholar]
  7. Hendry J. H. Quantitation of the radiotherapeutic importance of naturally-hypoxic normal tissues from collated experiments with rodents using single doses. Int J Radiat Oncol Biol Phys. 1979 Jul;5(7):971–976. doi: 10.1016/0360-3016(79)90602-3. [DOI] [PubMed] [Google Scholar]
  8. Phillips T. L. Rationale for initial clinical trials and future development of radioprotectors. Cancer Clin Trials. 1980 Summer;3(2):165–173. [PubMed] [Google Scholar]
  9. Purdie J. W. A comparative study of the radioprotective effects of cysteamine, WR-2721, and WR-1065 in cultured human cells. Radiat Res. 1979 Feb;77(2):303–311. [PubMed] [Google Scholar]
  10. Ritter M. A., Brown D. Q., Glover D. J., Yuhas J. M. In vitro studies on the absorption of WR-2721 by tumors and normal tissues. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):523–526. doi: 10.1016/0360-3016(82)90675-7. [DOI] [PubMed] [Google Scholar]
  11. Sutherland R. M., Durand R. E. Radiation response of multicell spheroids--an in vitro tumour model. Curr Top Radiat Res Q. 1976 Jan;11(1):87–139. [PubMed] [Google Scholar]
  12. Utley J. F., Marlowe C., Waddell W. J. Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2. Radiat Res. 1976 Nov;68(2):284–291. [PubMed] [Google Scholar]
  13. Vos O., Budke L., Grant G. A. In vitro evaluation of some latent radioprotective compounds. Int J Radiat Biol Relat Stud Phys Chem Med. 1976 Nov;30(5):433–448. doi: 10.1080/09553007614551251. [DOI] [PubMed] [Google Scholar]
  14. Yuhas J. M. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1980 May;40(5):1519–1524. [PubMed] [Google Scholar]
  15. Yuhas J. M. Protective drugs in cancer therapy: optimal clinical testing and future directions. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):513–517. doi: 10.1016/0360-3016(82)90673-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES